| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0360-3016(79)90554-6 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0360301679905546?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:0360301679905546?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 231023 |
| P2093 | author name string | P. Rubin | |
| O. M. Salazar | |||
| M. L. Feldstein | |||
| R. Pizzutiello | |||
| P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial | Q33453675 | ||
| Patterns of failure in intracranial astrocytomas after irradiation: analysis of dose and field factors | Q39977257 | ||
| The spread of glioblastoma multiforme as a determining factor in the radiation treated volume | Q40020366 | ||
| High dose radiation therapy in the treatment of glioblastoma multiforme: A preliminary report | Q40020396 | ||
| Fast-neutron irradiation of glioblastoma multiforme. Neuropathological analysis | Q40153121 | ||
| An analysis of dose-effect relationship in the radiotherapy of malignant gliomas | Q40285820 | ||
| Prognostic factors for patients with brain tumors | Q40892863 | ||
| The importance of distinguishing tumor grade in malignant gliomas: treatment and prognosis | Q48377562 | ||
| The proper nomenclature for glioblastoma multiforme | Q50723249 | ||
| A generalized Wilcoxon test for comparing arbitrarily singly-censored samples | Q56428666 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oncology | Q162555 |
| adaptive radiation therapy | Q180507 | ||
| P304 | page(s) | 1733-1740 | |
| P577 | publication date | 1979-10-01 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | High dose radiation therapy in the treatment of malignant gliomas: Final Report | |
| P478 | volume | 5 |
| Q35993865 | A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party |
| Q36045126 | A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma |
| Q48926304 | Accelerated fractionation radiotherapy for hospitalized glioblastoma multiforme patients with poor prognostic factors |
| Q52608753 | Advances in Glioblastoma Multiforme Treatment: New Models for Nanoparticle Therapy. |
| Q53655463 | Alterations in p53, p21, and MIB-1 labeling index in primary human astrocytomas following radiation therapy. |
| Q38845657 | Anaplastic astrocytoma |
| Q44125195 | Anaplastic astrocytoma |
| Q41779616 | Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. |
| Q55464325 | Association of the GNB3 825T-allele with better survival in patients with glioblastoma multiforme. |
| Q58804966 | Autophagic flux response and glioblastoma sensitivity to radiation |
| Q36468064 | Back to the future--radiotherapy in high grade gliomas |
| Q92446802 | Case-Based Review: newly diagnosed glioblastoma |
| Q55490615 | Cerebral space-occupying cysts following radiation and chemotherapy of malignant gliomas |
| Q42063200 | Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part II. |
| Q44067896 | Comparative treatment planning: Proton vs. x-ray beams against glioblastoma multiforme |
| Q34616722 | Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma |
| Q48548220 | Delayed adverse effects after irradiation of gliomas: clinicopathological analysis |
| Q39749274 | Fast neutron therapy for malignant astrocytomas. A review |
| Q38658258 | First Experience of Intraoperative Radiation Therapy in Cerebral High Grade Glioma in Iran: A Report of Three Cases and Literature Review |
| Q90618650 | Glioblastoma Treatment Modalities besides Surgery |
| Q55489919 | Glioblastoma multiforme: Treatment by large dose fraction irradiation and metronidazole |
| Q44761128 | Glioblastoma revisited: do clinical observations match basic science theory? Radiosurgery: clinical observations |
| Q48951467 | High-dose radiation therapy with low-dose (pulsed) BCNU in malignant gliomas: An eastern cooperative oncology group (ECOG) report |
| Q41524743 | Hyperfractionated and accelerated radiation therapy in central nervous system tumors (malignant gliomas, pediatric tumors, and brain metastases) |
| Q36501278 | Hypoxia imaging-directed radiation treatment planning |
| Q48252733 | In vitro model for the response to irradiation of different types of human intracranial tumours |
| Q34239497 | Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study |
| Q57384543 | Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cells |
| Q36808220 | Innovative Hypofractionated Stereotactic Regimen Achieves Excellent Local Control with No Radiation Necrosis: Promising Results in the Management of Patients with Small Recurrent Inoperable GBM |
| Q55482439 | Interstitial brachytherapy for low-grade cerebral gliomas: analysis of results in a series of 36 cases. |
| Q55482440 | Intra-operative radiation therapy for malignant brain tumors: rationale, method, and treatment results of cerebral glioblastomas. |
| Q24800235 | Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas |
| Q48602872 | Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial |
| Q48632153 | Misonidazole and irradiation in the treatment of high-grade astrocytomas: Further report of the Vienna study group |
| Q47732901 | Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Anaplastic Gliomas: Indian Single-center Data |
| Q55472680 | Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach. |
| Q36796882 | Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy |
| Q33956040 | New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab. |
| Q36643720 | Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study |
| Q36886481 | Protective effect on normal brain tissue during a combinational therapy of 2-deoxy-d-glucose and hypofractionated irradiation in malignant gliomas. |
| Q55482403 | Radiation therapy combined with radiosensitizing agents for cerebral glioblastoma in adults. |
| Q55463833 | Radiotherapy in adult glioblastomas |
| Q47273234 | Radiotherapy of glioblastoma multiforme. Feasibility of increased fraction size and shortened overall treatment |
| Q35225381 | Role for proton beam irradiation in treatment of pediatric cns malignancies |
| Q55476409 | Short-course radiotherapy in elderly and frail patients with glioblastoma multiforme. A phase II study. |
| Q55484186 | Should all patients with malignant astrocytoma have postoperative radiotherapy? |
| Q37144178 | Stereotactic radiosurgery for glioblastoma: retrospective analysis |
| Q40560864 | The basis for current treatment recommendations for malignant gliomas |
| Q55480630 | The relationship between the technical accuracy of stereotactic interstitial implantation for high grade gliomas and the pattern of tumor recurrence |
| Q48490574 | The treatment of adult supratentorial high grade astrocytomas |
| Q26764947 | Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve |
Search more.